Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

NZ stocks end flat as US Fed decision looms
Markets Market Close

NZ stocks end flat as US Fed decision looms

Market finishes slightly down as telco company Spark loses more ground.

Jamie Gray 12 Sep 2025
Locate Technologies plans to quit ASX for NZX
Markets

Locate Technologies plans to quit ASX for NZX

Bitcoin-favouring Locate Technologies eyes move to NZX's main board.

Staff reporters 12 Sep 2025
Vital takeover bid passes threshold at 11th hour
Markets

Vital takeover bid passes threshold at 11th hour

Tait International has secured acceptances to meet the 90% minimum condition for its Vital takeover less than a day before the offer was set to expire.Vital filed a substantial product holder (SPH) notice to the NZX on Friday morning, which showed Tait's stake lifted to 92.1%...

Gregor Thompson 12 Sep 2025
Tower again hikes FY underlying profit outlook
Markets

Tower again hikes FY underlying profit outlook

Insurer sees FY underling profit up as large events weigh less than expected     

Staff reporters 12 Sep 2025